Overview

A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

Status:
Completed

Trial end date:
2016-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if a combination of two drugs (bimatoprost and timolol) delivered to the surface of the eye over 10 weeks is better at lowering intraocular pressure (IOP) than either of the drugs delivered alone.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

ForSight Vision5, Inc.

Treatments:

Bimatoprost
Timolol